Jardiance®
empagliflozin
About Jardiance®
Treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control and to reduce the risk of cardiovascular death in patients with established cardiovascular disease.
Treatment of adults with symptomatic chronic heart failure across the full spectrum of left ventricular ejection fraction (LVEF), including both heart failure with reduced and preserved ejection fraction (HFrEF and HFpEF).
Professional Area
You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.
Product Key Facts
Indications
Type 2 diabetes mellitus
Chronic Heart Failure (HFrEF and HFpEF)
Brand Names
Jardiance® Jardianz®
Active ingredients
empagliflozin